Co-Authors
This is a "connection" page, showing publications co-authored by Sigrid Gouma and Madison Weirick.
Connection Strength
0.937
-
Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. JCI Insight. 2021 08 23; 6(16).
Score: 0.241
-
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity. 2021 09 14; 54(9):2133-2142.e3.
Score: 0.060
-
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy. JCO Oncol Pract. 2021 12; 17(12):e1879-e1886.
Score: 0.059
-
Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 2021 06 01; 175(6):594-600.
Score: 0.059
-
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19). J Pediatric Infect Dis Soc. 2021 May 28; 10(5):669-673.
Score: 0.059
-
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021 07; 27(7):1280-1289.
Score: 0.059
-
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination. Sci Immunol. 2021 04 15; 6(58).
Score: 0.059
-
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol. 2021 03 02; 6(57).
Score: 0.058
-
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. 2021 04 01; 184(7):1858-1864.e10.
Score: 0.058
-
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome. Pediatr Blood Cancer. 2020 11; 67(11):e28693.
Score: 0.056
-
SARS-CoV-2 seroprevalence among parturient women in Philadelphia. Sci Immunol. 2020 07 29; 5(49).
Score: 0.056
-
Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 2020 07 15; 5(49).
Score: 0.056
-
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020 09 04; 369(6508).
Score: 0.056